ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Investing Strategies
2 ASX 200 shares to buy in the most 'interesting' sector right now
Broker Notes
Bell Potter names the best ASX shares to buy in March
Share Market News
Up 37% from their low: Can ResMed shares keep rising?
Cheap Shares
3 reliable ASX shares you can buy at a discount
Share Market News
Here are the top 10 ASX 200 shares today
Broker Notes
Morgans names more of the best ASX 200 shares to buy in March
Share Fallers
2 classic ASX 200 shares you can buy for cheap now to hold for years
Broker Notes
These ASX 200 shares could rise 20% to 50%
Blue Chip Shares
Here are 2 high-quality ASX 200 blue chip shares that analysts are bullish on
Share Fallers
Why Australian Finance Group, Chalice, DroneShield, and ResMed are sinking today
Broker Notes
3 no-brainer ASX shares to buy under $30
Healthcare Shares
Here's why ResMed shares can jump a further 20%
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.